Part of a long slate of annual Family Weekend programming, the expo was organized to highlight undergraduate research.
Board members discussed the Pan-University Entrepreneurship Initiative, a project that aims to help develop more entrepreneurial ventures at the University.
After a two-year hiatus due to the COVID-19 pandemic, the Center for Global Health Equity’s Research Symposium Scholar Poster Presentations returned in-person Friday afternoon at the Corner Building.
According to a recent U.Va. Health study, premenstrual symptoms affect a significant number of those who menstruate, with about a third of the study’s participants reporting that PMS affected their daily activities each menstrual cycle.
The glacier has retreated twice as rapidly as expected.
Biomedical Engineering Prof. Kimberly Kelly and her team have pioneered a new antibody therapy for pancreatic cancer that is now in phase 1A dose escalation safety trial.
The NDE research in the Greyson lab works to help society deal more realistically with the transition from life to death, while redefining the standard concept of consciousness in medicine.
In hopes of a future with less obesity, School of Medicine researchers have put their efforts into the potential treatment of Type 2 Diabetes.
The University will invest more than $75 million in neuroscience research, announced June 3 at the Board of Visitors’ meeting.
After four years of learning at the University, three social science students share their unique experiences in conducting research as undergraduates.
Half of all donated pediatric hearts are discarded, and 20 percent of children on the waitlist for a donor heart die before receiving one.
The stigma of mental illness isolates those who are suffering, breaks relationships, makes it difficult for them to get jobs and keeps them from getting help.
The new tool, called Giraffe, is the first step toward making the original reference genome from the Human Genomics Project much more robust.
The medication can be put into use right away, should the study prove effective.
Experts have dramatically transformed Virginia coastline through the largest and most successful seagrass restoration project in the world.
Asst. Neurology Prof. Nicholas Brenton spearheaded the new research, exploring how a modified Atkins diet has the potential to be a new standard of care for MS patients.
The American Society for Clinical Oncology, including the U.Va. Cancer Center, called for a panel of medical professionals to reassess the pre-existing protocol for brain cancer treatment
James Smith, environmental and civil engineering professor, set out to create a product that would be able to disinfect the water.
Recently, Charlottesville based medical device company, Icarus Medical, received a $600,000 research grant to aid in the development and production of their knee braces.
